Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP2A6 | P11509 | 7/20 | 0.62 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.62 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.62 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.62 |
| ▸ | CYP11B1 | P15538 | 4/20 | 0.58 |
| ▸ | CYP11B2 | P19099 | 4/20 | 0.58 |
| ▸ | MKNK1 | Q9BUB5 | 2/20 | 0.50 |
| ▸ | MKNK2 | Q9HBH9 | 2/20 | 0.50 |
| ▸ | MEN1 | O00255 | 1/20 | 0.50 |
| ▸ | PSIP1 | O75475 | 1/20 | 0.50 |
| ▸ | AXL | P30530 | 1/20 | 0.50 |
| ▸ | CYP19A1 | P11511 | 2/20 | 0.48 |
| ▸ | DYRK1A | Q13627 | 1/20 | 0.48 |
| ▸ | DYRK1B | Q9Y463 | 1/20 | 0.48 |
| ▸ | CYP17A1 | P05093 | 1/20 | 0.48 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.48 |
| ▸ | LMNA | P02545 | 1/20 | 0.48 |
| ▸ | TP53 | P04637 | 1/20 | 0.48 |
| ▸ | MAPT | P10636 | 1/20 | 0.48 |
| ▸ | HPGD | P15428 | 1/20 | 0.48 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30335566 | 1.00 | CYP2A6 (0.62) | CYP2A6ALDH1A1CYP3A4CYP1A2CYP11B1 | |
| SCHEMBL12576018 | 0.94 | CYP11B1 (0.57) | CYP2A6ALDH1A1CYP3A4CYP1A2CYP11B1 | |
| SCHEMBL21311982 | 0.93 | CYP11B1 (0.56) | CYP2A6ALDH1A1CYP3A4CYP1A2CYP11B1 | |
| SCHEMBL12129641 | 0.93 | CYP11B1 (0.56) | CYP2A6ALDH1A1CYP3A4CYP1A2CYP11B1 | |
| SCHEMBL13244061 | 0.85 | CYP2A6 (0.65) | CYP2A6ALDH1A1CYP3A4CYP1A2CYP11B1 | |
| SCHEMBL9656595 | 0.85 | CYP2A6 (0.65) | CYP2A6ALDH1A1CYP3A4CYP1A2CYP11B1 | |
| SCHEMBL30687563 | 0.85 | CYP2A6 (0.65) | CYP2A6ALDH1A1CYP3A4CYP1A2CYP11B1 | |
| SCHEMBL21312051 | 0.85 | CYP2A6 (0.65) | CYP2A6ALDH1A1CYP3A4CYP1A2CYP11B1 | |
| SCHEMBL30398823 | 0.85 | CYP2A6 (0.65) | CYP2A6ALDH1A1CYP3A4CYP1A2CYP11B1 | |
| SCHEMBL1935147 | 0.85 | CYP11B1 (0.49) | CYP2A6ALDH1A1CYP3A4CYP1A2CYP11B1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 42 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-108912154-B | Base material for preparing bipolar electroluminescent material | 大连理工大学 | 2021-04-16 | — | — | CN | claimed |
| CN-108752372-B | Compound for preparing organic electroluminescent material | 大连理工大学 | 2021-01-22 | — | — | CN | claimed |
| CN-111606887-B | Novel kinase inhibitor | 安徽中科拓苒药物科学研究有限公司 | 2023-03-17 | — | — | CN | disclosed |
| CN-108912154-B | Base material for preparing bipolar electroluminescent material | 大连理工大学 | 2021-04-16 | — | — | CN | disclosed |
| CN-109053690-B | Bipolar electroluminescent material containing carbazole group and application thereof | 大连理工大学 | 2021-04-16 | — | — | CN | disclosed |
| CN-108752372-B | Compound for preparing organic electroluminescent material | 大连理工大学 | 2021-01-22 | — | — | CN | disclosed |
| CN-111606887-A | Novel kinase inhibitor | 安徽中科拓苒药物科学研究有限公司 | 2020-09-01 | — | — | CN | disclosed |
| US-20190312213-A1 | ORGANIC ELECTROLUMINESCENT MATERIAL AND APPLICATION THEREOF | DALIAN UNIVERSITY OF TECHNOLOGY (CN) | 2019-10-10 | — | — | US | disclosed |
| US-9379336-B2 | Compounds for use in light emitting devices | NITTO DENKO CORPORATION (JP) | 2016-06-28 | — | — | US | disclosed |
| US-9379336-B2 | Compounds for use in light emitting devices | NITTO DENKO CORPORATION (JP) | 2016-06-28 | — | — | US | disclosed |
| US-9379336-B2 | Compounds for use in light emitting devices | NITTO DENKO CORPORATION (JP) | 2016-06-28 | — | — | US | disclosed |
| US-7365174-B2 | Azalide and azalactam derivatives and method for producing the same | MEIJI SEIKA KAISHA, LTD. (JP) | 2008-04-29 | — | — | US | disclosed |
| CN-100343237-C | Amide derivative and medicine | NIPPON SHINYAKU CO LTD (JP) | 2007-10-17 | — | — | CN | disclosed |
| US-20070042974-A1 | Nozel azalide and azalactam derivatives and method for producing the same | MEIJI SEIKA KAISHA, LTD. (JP) | 2007-02-22 | — | — | US | disclosed |
| EP-1661904-A1 | NOVEL AZALIDE AND AZALACTAM DERIVATIVES AND PROCESS FOR THE PRODUCTION OF THE SAME | MEIJI SEIKA KAISHA LTD. (JP) | 2006-05-31 | — | — | EP | disclosed |
| US-20060014742-A1 | Amide derivative | NIPPON SHINYAKU CO., LTD. (JP) | 2006-01-19 | — | — | US | disclosed |
| CN-1678590-A | Amide derivative and pharmaceutical | NIPPON SHINYAKU CO LTD (JP) | 2005-10-05 | — | — | CN | disclosed |
| EP-1533304-A1 | AMIDE DERIVATIVE | Nippon Shinyaku Co., Ltd. (JP) | 2005-05-25 | — | — | EP | disclosed |
| US-5409920-A | 2-(3-pyridyl)-carbapenem antibacterial agents | MERCK & CO., INC. (US) | 1995-04-25 | — | — | US | disclosed |
| EP-0479574-A2 | 2-(3-pyridyl)-carbapenem antibacterial agents | MERCK & CO. INC. (US) | 1992-04-08 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20060014742-A1 | Amide derivative | ABL1, ABL2, BCR | CYP2A6 239/4885ALDH1A1 753/4885CYP3A4 1045/4885 |
| US-20070042974-A1 | Nozel azalide and azalactam derivatives and method for producing the same | BCL6, NR4A1, NR4A2 | CYP2A6 23/4885ALDH1A1 1363/4885CYP3A4 297/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.